Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,323,998
-$1,520,653 QoQ
Shares Held
345,681
-1.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#455
of 2,816 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McMillan Office, Inc. holds $62,031,168 across 15 Drug Manufacturers - General names. PFE ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
78,610 | $19,781,420 | |
| 2 | JNJ |
Johnson & Johnson
|
49,167 | $12,486,942 | |
| 3 | PFE |
Pfizer Inc
This page
|
345,681 | $8,323,998 | |
| 4 | NVO |
Novo Nordisk A S
|
107,419 | $5,149,666 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,193 | $4,563,100 | |
| 6 | LLY |
ELI LILLY & Co
|
3,626 | $4,349,133 | |
| 7 | MRK |
Merck & Co., Inc.
|
31,930 | $4,103,005 | |
| 8 | AMGN |
Amgen Inc
|
5,530 | $2,002,523 |
All Filings in PFE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,323,998 | 345,681 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,844,651 | 350,593 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $9,054,312 | 363,627 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||